Evaluating treatment response involves various methods, including physical exams, blood tests, imaging studies, and repeated biopsies. The goal is to determine if the cancer has shrunk, remained stable, or progressed. Standard criteria like RECIST (Response Evaluation Criteria in Solid Tumors) are often used. Understanding treatment response is key to adjusting therapy and improving outcomes.